(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -98.57%532 | 7,440.26%273.79K | -95.05%2.06K | -95.05%2.06K | -99.23%1.62K | -93.53%37.3K | -98.33%3.63K | -87.57%41.61K | -87.57%41.61K | -77.82%210.51K |
-Cash and cash equivalents | -98.57%532 | 7,440.26%273.79K | -95.05%2.06K | -95.05%2.06K | -99.23%1.62K | -93.53%37.3K | -98.33%3.63K | -87.57%41.61K | -87.57%41.61K | -77.82%210.51K |
-Accounts receivable | -91.82%500 | -90.92%566 | -90.92%566 | -90.92%566 | --6.11K | --6.11K | --6.24K | 17.24%6.24K | 17.24%6.24K | ---- |
Total current assets | -82.36%27.54K | 109.98%300.86K | -92.76%15.33K | -92.76%15.33K | -92.56%120.43K | -90.69%156.11K | -77.72%143.28K | -66.18%211.81K | -66.18%211.81K | -5.70%1.62M |
Non current assets | ||||||||||
-Long term equity investment | ---- | ---- | ---- | ---- | ---- | ---- | --64.8K | --55.9K | --55.9K | ---- |
-Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -62.56%642.61K |
-Other intangible assets | ---- | ---- | ---- | ---- | ---- | --51.97K | ---- | ---- | ---- | ---- |
Regulatory assets | -99.53%500 | -99.47%566 | -99.47%566 | -99.47%566 | -57.16%106.11K | 142.58%106.11K | 99.08%106.24K | 180.91%106.24K | 180.91%106.24K | --247.66K |
Total assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --37.66K |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | -60.10%90.27K | -60.05%89.37K | -60.05%89.37K | -57.18%91.38K |
-Current debt | ---- | ---- | ---- | ---- | ---- | ---- | -60.10%90.27K | -60.05%89.37K | -60.05%89.37K | -57.18%91.38K |
-accounts payable | 63.05%706.66K | 59.36%484.53K | 63.65%461.84K | 63.65%461.84K | --409.41K | --433.39K | --304.04K | 8.78%282.21K | 8.78%282.21K | ---- |
-Total tax payable | --0 | --0 | --0 | --0 | --0 | --0 | --207.8K | --201.9K | --201.9K | --0 |
Current accrued expenses | --0 | -37.50%37.5K | -37.50%37.5K | -37.50%37.5K | --12.5K | --20K | --60K | --60K | --60K | ---- |
Current deferred liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%123K |
Current liabilities | 55.86%706.66K | 14.91%522.03K | 15.70%499.34K | 15.70%499.34K | -7.66%421.91K | -25.12%453.39K | -30.26%454.31K | -28.80%431.58K | -28.80%431.58K | -33.05%456.92K |
Non current liabilities | ||||||||||
Derivative product liabilities | ---- | ---- | --0 | --0 | --0 | --0 | --143K | --146K | --146K | ---- |
Long term provisions | ---- | ---- | ---- | ---- | ---- | ---- | --64.8K | --55.9K | --55.9K | ---- |
Total non current liabilities | 55.86%706.66K | -21.16%522.03K | -21.17%499.34K | -21.17%499.34K | -7.66%421.91K | -25.12%453.39K | 1.64%662.11K | 4.52%633.48K | 4.52%633.48K | -33.05%456.92K |
Shareholders'equity | ||||||||||
Share capital | 2.58%12.86M | 5.08%12.86M | 3.16%12.62M | 3.16%12.62M | 2.19%12.63M | 5.76%12.53M | 20.99%12.24M | 20.99%12.24M | 20.99%12.24M | 22.23%12.36M |
-common stock | 2.58%12.86M | 5.08%12.86M | 3.16%12.62M | 3.16%12.62M | 2.19%12.63M | 5.76%12.53M | 20.99%12.24M | 20.99%12.24M | 20.99%12.24M | 22.23%12.36M |
Additional paid-in capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 430.66%1.2M |
Gains losses not affecting retained earnings | 8.21%1.52M | 8.77%1.52M | 5.29%1.27M | 5.29%1.27M | --1.41M | --1.41M | --1.4M | 55.60%1.21M | 55.60%1.21M | ---- |
Total equity | -14.14%644.04K | -11.35%667.36K | -54.65%372.43K | -54.65%372.43K | -74.76%736.92K | -74.84%750.11K | -58.60%752.76K | -54.80%821.29K | -54.80%821.29K | -29.82%2.92M |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data